Keywords
Last Name
Institution

Joshua Hare

TitleSENIOR FACULTY
InstitutionMount Sinai
DepartmentCardiology
Address

     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Heldman AW, Difede DL, Fishman JE, Zambrano JP, Trachtenberg BH, Karantalis V, Mushtaq M, Williams AR, Suncion VY, McNiece IK, Ghersin E, Soto V, Lopera G, Miki R, Willens H, Hendel R, Mitrani R, Pattany P, Feigenbaum G, Oskouei B, Byrnes J, Lowery MH, Sierra J, Pujol MV, Delgado C, Gonzalez PJ, Rodriguez JE, Bagno LL, Rouy D, Altman P, Foo CW, da Silva J, Anderson E, Schwarz R, Mendizabal A, Hare JM. Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy: The TAC-HFT Randomized Trial. JAMA. 2014 Jan 1; 311(1):62-73.
      View in: PubMed
    2. Miranda LF, Rodrigues CO, Ramachandran S, Torres E, Huang J, Klim J, Hehre D, McNiece I, Hare JM, Suguihara CY, Young KC. Stem cell factor improves lung recovery in rats following neonatal hyperoxia-induced lung injury. Pediatr Res. 2013 Dec; 74(6):682-8.
      View in: PubMed
    3. Telukuntla KS, Suncion VY, Schulman IH, Hare JM. The advancing field of cell-based therapy: insights and lessons from clinical trials. J Am Heart Assoc. 2013 Oct; 2(5):e000338.
      View in: PubMed
    4. Rangel EB, Gomes SA, Dulce RA, Premer C, Rodrigues CO, Kanashiro-Takeuchi RM, Oskouei B, Carvalho DA, Ruiz P, Reiser J, Hare JM. C-kit(+) cells isolated from developing kidneys are a novel population of stem cells with regenerative potential. Stem Cells. 2013 Aug; 31(8):1644-56.
      View in: PubMed
    5. Matthay MA, Anversa P, Bhattacharya J, Burnett BK, Chapman HA, Hare JM, Hei DJ, Hoffman AM, Kourembanas S, McKenna DH, Ortiz LA, Ott HC, Tente W, Thébaud B, Trapnell BC, Weiss DJ, Yuan JX, Blaisdell CJ. Cell therapy for lung diseases. Report from an NIH-NHLBI workshop, November 13-14, 2012. Am J Respir Crit Care Med. 2013 Aug 1; 188(3):370-5.
      View in: PubMed
    6. Glassberg MK, Hare JM, Toonkel RL, Matthay MA. Reply: idiopathic pulmonary fibrosis: a degenerative disease requiring a regenerative approach. Am J Respir Crit Care Med. 2013 Jul 15; 188(2):253-4.
      View in: PubMed
    7. Toonkel RL, Hare JM, Matthay MA, Glassberg MK. Mesenchymal stem cells and idiopathic pulmonary fibrosis. Potential for clinical testing. Am J Respir Crit Care Med. 2013 Jul 15; 188(2):133-40.
      View in: PubMed
    8. Tanawuttiwat T, Sager SJ, Hare JM, Myerburg RJ. Myocarditis and ARVC/D: variants or mimics? Heart Rhythm. 2013 Oct; 10(10):1544-8.
      View in: PubMed
    9. Kazmierczak K, Paulino EC, Huang W, Muthu P, Liang J, Yuan CC, Rojas AI, Hare JM, Szczesna-Cordary D. Discrete effects of A57G-myosin essential light chain mutation associated with familial hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol. 2013 Aug 15; 305(4):H575-89.
      View in: PubMed
    10. Selem SM, Kaushal S, Hare JM. Stem cell therapy for pediatric dilated cardiomyopathy. Curr Cardiol Rep. 2013 Jun; 15(6):369.
      View in: PubMed
    11. Williams AR, Suncion VY, McCall F, Guerra D, Mather J, Zambrano JP, Heldman AW, Hare JM. Durable scar size reduction due to allogeneic mesenchymal stem cell therapy regulates whole-chamber remodeling. J Am Heart Assoc. 2013 Jun; 2(3):e000140.
      View in: PubMed
    12. Hare JM, Bolli R, Cooke JP, Gordon DJ, Henry TD, Perin EC, March KL, Murphy MP, Pepine CJ, Simari RD, Skarlatos SI, Traverse JH, Willerson JT, Szady AD, Taylor DA, Vojvodic RW, Yang PC, Moyé LA. Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN). Circulation. 2013 Apr 16; 127(15):1630-5.
      View in: PubMed
    13. Hare JM, Difede D, Heldman AW. Use of stem cells for ischemic cardiomyopathy--reply. JAMA. 2013 Apr 10; 309(14):1458-9.
      View in: PubMed
    14. Karantalis V, Schulman IH, Hare JM. Nitroso-redox imbalance affects cardiac structure and function. J Am Coll Cardiol. 2013 Mar 5; 61(9):933-5.
      View in: PubMed
    15. Goldstein BJ, Hare JM, Lieberman S, Casiano R. Adult human nasal mesenchymal stem cells have an unexpected broad anatomic distribution. Int Forum Allergy Rhinol. 2013 Jul; 3(7):550-5.
      View in: PubMed
    16. Dulce RA, Yiginer O, Gonzalez DR, Goss G, Feng N, Zheng M, Hare JM. Hydralazine and organic nitrates restore impaired excitation-contraction coupling by reducing calcium leak associated with nitroso-redox imbalance. J Biol Chem. 2013 Mar 1; 288(9):6522-33.
      View in: PubMed
    17. Gomes SA, Rangel EB, Premer C, Dulce RA, Cao Y, Florea V, Balkan W, Rodrigues CO, Schally AV, Hare JM. S-nitrosoglutathione reductase (GSNOR) enhances vasculogenesis by mesenchymal stem cells. Proc Natl Acad Sci U S A. 2013 Feb 19; 110(8):2834-9.
      View in: PubMed
    18. Da Silva JS, Hare JM. Cell-based therapies for myocardial repair: emerging role for bone marrow-derived mesenchymal stem cells (MSCs) in the treatment of the chronically injured heart. Methods Mol Biol. 2013; 1037:145-63.
      View in: PubMed
    19. Hare JM, Fishman JE, Gerstenblith G, DiFede Velazquez DL, Zambrano JP, Suncion VY, Tracy M, Ghersin E, Johnston PV, Brinker JA, Breton E, Davis-Sproul J, Schulman IH, Byrnes J, Mendizabal AM, Lowery MH, Rouy D, Altman P, Wong Po Foo C, Ruiz P, Amador A, Da Silva J, McNiece IK, Heldman AW, George R, Lardo A. Comparison of allogeneic vs autologous bone marrow–derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial. JAMA. 2012 Dec 12; 308(22):2369-79.
      View in: PubMed
    20. Williams AR, Hatzistergos KE, Addicott B, McCall F, Carvalho D, Suncion V, Morales AR, Da Silva J, Sussman MA, Heldman AW, Hare JM. Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after myocardial infarction. Circulation. 2013 Jan 15; 127(2):213-23.
      View in: PubMed
    21. Parakh K, Kittleson MM, Heidecker B, Wittstein IS, Judge DP, Champion HC, Barouch LA, Baughman KL, Russell SD, Kasper EK, Sitammagari KK, Hare JM. The variable natural history of idiopathic dilated cardiomyopathy. Isr Med Assoc J. 2012 Nov; 14(11):666-71.
      View in: PubMed
    22. Schulman IH, Hare JM. Key developments in stem cell therapy in cardiology. Regen Med. 2012 Nov; 7(6 Suppl):17-24.
      View in: PubMed
    23. Zhu S, Deng S, Ma Q, Zhang T, Jia C, Zhuo D, Yang F, Wei J, Wang L, Dykxhoorn DM, Hare JM, Goldschmidt-Clermont PJ, Dong C. MicroRNA-10A* and MicroRNA-21 modulate endothelial progenitor cell senescence via suppressing high-mobility group A2. Circ Res. 2013 Jan 4; 112(1):152-64.
      View in: PubMed
    24. Li J, Kritzer MD, Michel JJ, Le A, Thakur H, Gayanilo M, Passariello CL, Negro A, Danial JB, Oskouei B, Sanders M, Hare JM, Hanauer A, Dodge-Kafka K, Kapiloff MS. Anchored p90 ribosomal S6 kinase 3 is required for cardiac myocyte hypertrophy. Circ Res. 2013 Jan 4; 112(1):128-39.
      View in: PubMed
    25. Friedewald VE, Hare JM, Miller LW, Walpole HT, Willerson JT, Roberts WC. The editor's roundtable: advances in stem cell therapy for treatment of cardiovascular disease. Am J Cardiol. 2012 Sep 15; 110(6):807-16.
      View in: PubMed
    26. McCall FC, Telukuntla KS, Karantalis V, Suncion VY, Heldman AW, Mushtaq M, Williams AR, Hare JM. Myocardial infarction and intramyocardial injection models in swine. Nat Protoc. 2012 Aug; 7(8):1479-96.
      View in: PubMed
    27. Kulandavelu S, Hare JM. Alterations in ß3-adrenergic cardiac innervation and nitric oxide signaling in heart failure. J Am Coll Cardiol. 2012 May 29; 59(22):1988-90.
      View in: PubMed
    28. Karantalis V, Balkan W, Schulman IH, Hatzistergos KE, Hare JM. Cell-based therapy for prevention and reversal of myocardial remodeling. Am J Physiol Heart Circ Physiol. 2012 Aug 1; 303(3):H256-70.
      View in: PubMed
    29. Blum A, Balkan W, Hare JM. Advances in cell-based therapy for peripheral vascular disease. Atherosclerosis. 2012 Aug; 223(2):269-77.
      View in: PubMed
    30. Ueta CB, Oskouei BN, Olivares EL, Pinto JR, Correa MM, Simovic G, Simonides WS, Hare JM, Bianco AC. Absence of myocardial thyroid hormone inactivating deiodinase results in restrictive cardiomyopathy in mice. Mol Endocrinol. 2012 May; 26(5):809-18.
      View in: PubMed
    31. Beigi F, Gonzalez DR, Minhas KM, Sun QA, Foster MW, Khan SA, Treuer AV, Dulce RA, Harrison RW, Saraiva RM, Premer C, Schulman IH, Stamler JS, Hare JM. Dynamic denitrosylation via S-nitrosoglutathione reductase regulates cardiovascular function. Proc Natl Acad Sci U S A. 2012 Mar 13; 109(11):4314-9.
      View in: PubMed
    32. Oskouei BN, Lamirault G, Joseph C, Treuer AV, Landa S, Da Silva J, Hatzistergos K, Dauer M, Balkan W, McNiece I, Hare JM. Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair. Stem Cells Transl Med. 2012 Feb; 1(2):116-24.
      View in: PubMed
    33. Mazhari R, Hare JM. Translational findings from cardiovascular stem cell research. Trends Cardiovasc Med. 2012 Jan; 22(1):1-6.
      View in: PubMed
    34. Kanashiro-Takeuchi RM, Takeuchi LM, Rick FG, Dulce R, Treuer AV, Florea V, Rodrigues CO, Paulino EC, Hatzistergos KE, Selem SM, Gonzalez DR, Block NL, Schally AV, Hare JM. Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after myocardial infarction (MI). Proc Natl Acad Sci U S A. 2012 Jan 10; 109(2):559-63.
      View in: PubMed
    35. Dulce RA, Balkan W, Hare JM, Schulman IH. Wnt signalling: a mediator of the heart-bone marrow axis after myocardial injury? Eur Heart J. 2012 Aug; 33(15):1861-3.
      View in: PubMed
    36. Suncion VY, Schulman IH, Hare JM. Concise review: the role of clinical trials in deciphering mechanisms of action of cardiac cell-based therapy. Stem Cells Transl Med. 2012 Jan; 1(1):29-35.
      View in: PubMed
    37. Taylor AL, Hare JM, Mann DL. Letter by Taylor et al regarding article, "Hydralazine and isosorbide dinitrate in heart failure: historical perspectives, mechanisms, and future directions". Circulation. 2011 Dec 6; 124(23):e778; author reply e779.
      View in: PubMed
    38. Hare JM. Bone marrow therapy for myocardial infarction. JAMA. 2011 Nov 16; 306(19):2156-7.
      View in: PubMed
    39. Sadoshima J, Hare JM. Meeting report for Basic Cardiovascular Sciences 2011 Scientific Sessions: from concept to clinic: leading cardiovascular translational science. Circ Res. 2011 Nov 11; 109(11):1204-5.
      View in: PubMed
    40. Harzand A, Tamariz L, Hare JM. Uric acid, heart failure survival, and the impact of xanthine oxidase inhibition. Congest Heart Fail. 2012 May-Jun; 18(3):179-82.
      View in: PubMed
    41. Hullinger TG, Montgomery RL, Seto AG, Dickinson BA, Semus HM, Lynch JM, Dalby CM, Robinson K, Stack C, Latimer PA, Hare JM, Olson EN, van Rooij E. Inhibition of miR-15 protects against cardiac ischemic injury. Circ Res. 2012 Jan 6; 110(1):71-81.
      View in: PubMed
    42. Rogers SN, Harvey-Woodworth CN, Hare J, Leong P, Lowe D. Patients' perception of the financial impact of head and neck cancer and the relationship to health related quality of life. Br J Oral Maxillofac Surg. 2012 Jul; 50(5):410-6.
      View in: PubMed
    43. Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutiérrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, Feldman HI, St John Sutton M, Ojo A, Gadegbeku C, Di Marco GS, Reuter S, Kentrup D, Tiemann K, Brand M, Hill JA, Moe OW, Kuro-O M, Kusek JW, Keane MG, Wolf M. FGF23 induces left ventricular hypertrophy. J Clin Invest. 2011 Nov; 121(11):4393-408.
      View in: PubMed
    44. Shehadeh LA, Webster KA, Hare JM, Vazquez-Padron RI. Dynamic regulation of vascular myosin light chain (MYL9) with injury and aging. PLoS One. 2011; 6(10):e25855.
      View in: PubMed
    45. Williams AR, Hare JM. Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res. 2011 Sep 30; 109(8):923-40.
      View in: PubMed
    46. Tanawuttiwat T, Trachtenberg BH, Hershberger RE, Hare JM, Cohen MG. Dual percutaneous mechanical circulatory support as a bridge to recovery in fulminant myocarditis. ASAIO J. 2011 Sep-Oct; 57(5):477-9.
      View in: PubMed
    47. Junttila MJ, Fishman JE, Lopera GA, Pattany PM, Velazquez DL, Williams AR, Trachtenberg BH, Sanina C, Mather J, Hare JM. Safety of serial MRI in patients with implantable cardioverter defibrillators. Heart. 2011 Nov; 97(22):1852-6.
      View in: PubMed
    48. Kanashiro-Takeuchi RM, Takeuchi LM, Hatzistergos K, Quevedo H, Selem SM, Treuer AV, Premer C, Balkan W, Margitich I, Song Y, Hu Q, Hare JM. Effects of combination of proliferative agents and erythropoietin on left ventricular remodeling post-myocardial infarction. Clin Transl Sci. 2011 Jun; 4(3):168-74.
      View in: PubMed
    49. Kanashiro-Takeuchi RM, Schulman IH, Hare JM. Pharmacologic and genetic strategies to enhance cell therapy for cardiac regeneration. J Mol Cell Cardiol. 2011 Oct; 51(4):619-25.
      View in: PubMed
    50. Hatzistergos KE, Blum A, Ince T, Grichnik JM, Hare JM. What is the oncologic risk of stem cell treatment for heart disease? Circ Res. 2011 May 27; 108(11):1300-3.
      View in: PubMed
    51. Schulman IH, Hare JM. Regulation of cardiovascular cellular processes by S-nitrosylation. Biochim Biophys Acta. 2012 Jun; 1820(6):752-62.
      View in: PubMed
    52. Rame JE, Barouch LA, Sack MN, Lynn EG, Abu-Asab M, Tsokos M, Kern SJ, Barb JJ, Munson PJ, Halushka MK, Miller KL, Fox-Talbot K, Zhang J, Hare JM, Solomon MA, Danner RL. Caloric restriction in leptin deficiency does not correct myocardial steatosis: failure to normalize PPAR{alpha}/PGC1{alpha} and thermogenic glycerolipid/fatty acid cycling. Physiol Genomics. 2011 Jun 28; 43(12):726-38.
      View in: PubMed
    53. Williams AR, Trachtenberg B, Velazquez DL, McNiece I, Altman P, Rouy D, Mendizabal AM, Pattany PM, Lopera GA, Fishman J, Zambrano JP, Heldman AW, Hare JM. Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: functional recovery and reverse remodeling. Circ Res. 2011 Apr 1; 108(7):792-6.
      View in: PubMed
    54. Heidecker B, Kittleson MM, Kasper EK, Wittstein IS, Champion HC, Russell SD, Hruban RH, Rodriguez ER, Baughman KL, Hare JM. Transcriptomic biomarkers for the accurate diagnosis of myocarditis. Circulation. 2011 Mar 22; 123(11):1174-84.
      View in: PubMed
    55. Dulce RA, Schulman IH, Hare JM. S-glutathionylation: a redox-sensitive switch participating in nitroso-redox balance. Circ Res. 2011 Mar 4; 108(5):531-3.
      View in: PubMed
    56. Trachtenberg B, Velazquez DL, Williams AR, McNiece I, Fishman J, Nguyen K, Rouy D, Altman P, Schwarz R, Mendizabal A, Oskouei B, Byrnes J, Soto V, Tracy M, Zambrano JP, Heldman AW, Hare JM. Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: A randomized, double-blind, placebo-controlled study of safety and efficacy. Am Heart J. 2011 Mar; 161(3):487-93.
      View in: PubMed
    57. Mushtaq M, Oskouei BN, Hare JM. Cell therapy for heart disease: to genetically modify or not, that is the question. Circ Res. 2011 Feb 18; 108(4):398-401.
      View in: PubMed
    58. Tamariz L, Harzand A, Palacio A, Verma S, Jones J, Hare J. Uric acid as a predictor of all-cause mortality in heart failure: a meta-analysis. Congest Heart Fail. 2011 Jan-Feb; 17(1):25-30.
      View in: PubMed
    59. Heldman AW, Zambrano JP, Hare JM. Cell therapy for heart disease: where are we in 2011? J Am Coll Cardiol. 2011 Jan 25; 57(4):466-8.
      View in: PubMed
    60. Cires RS, Patel H, Tamariz LJ, Hare JM, Zambrano JP. Effect of granulocyte-colony stimulating factor on systolic function of oncology patients. J Am Coll Cardiol. 2011 Jan 25; 57(4):516-7.
      View in: PubMed
    61. Goldschmidt-Clermont PJ, Seo DM, Wang L, Beecham GW, Liu ZJ, Vazquez-Padron RI, Dong C, Hare JM, Kapiloff MS, Bishopric NH, Pericak-Vance M, Vance JM, Velazquez OC. Inflammation, stem cells and atherosclerosis genetics. Curr Opin Mol Ther. 2010 Dec; 12(6):712-23.
      View in: PubMed
    62. Gregg CJ, Steppan J, Gonzalez DR, Champion HC, Phan AC, Nyhan D, Shoukas AA, Hare JM, Barouch LA, Berkowitz DE. ß2-adrenergic receptor-coupled phosphoinositide 3-kinase constrains cAMP-dependent increases in cardiac inotropy through phosphodiesterase 4 activation. Anesth Analg. 2010 Oct; 111(4):870-7.
      View in: PubMed
    63. Schulman IH, Zhou MS, Treuer AV, Chadipiralla K, Hare JM, Raij L. Altered renal expression of angiotensin II receptors, renin receptor, and ACE-2 precede the development of renal fibrosis in aging rats. Am J Nephrol. 2010; 32(3):249-61.
      View in: PubMed
    64. Addicott B, Willman M, Rodriguez J, Padgett K, Han D, Berman D, Hare JM, Kenyon NS. Mesenchymal stem cell labeling and in vitro MR characterization at 1.5 T of new SPIO contrast agent: Molday ION Rhodamine-B™. Contrast Media Mol Imaging. 2011 Jan-Feb; 6(1):7-18.
      View in: PubMed
    65. Hatzistergos KE, Quevedo H, Oskouei BN, Hu Q, Feigenbaum GS, Margitich IS, Mazhari R, Boyle AJ, Zambrano JP, Rodriguez JE, Dulce R, Pattany PM, Valdes D, Revilla C, Heldman AW, McNiece I, Hare JM. Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation. Circ Res. 2010 Oct 1; 107(7):913-22.
      View in: PubMed
    66. Gonzalez DR, Treuer AV, Castellanos J, Dulce RA, Hare JM. Impaired S-nitrosylation of the ryanodine receptor caused by xanthine oxidase activity contributes to calcium leak in heart failure. J Biol Chem. 2010 Sep 10; 285(37):28938-45.
      View in: PubMed
    67. Christoforou N, Oskouei BN, Esteso P, Hill CM, Zimmet JM, Bian W, Bursac N, Leong KW, Hare JM, Gearhart JD. Implantation of mouse embryonic stem cell-derived cardiac progenitor cells preserves function of infarcted murine hearts. PLoS One. 2010; 5(7):e11536.
      View in: PubMed
    68. White AR, Ryoo S, Bugaj L, Attarzadeh DO, Thiyagarajan S, Chen K, Attwater S, Abbot B, Li D, Champion HC, Shoukas AA, Nyhan D, Hare JM, Berkowitz DE, Tuday EC. Early changes in vasoreactivity after simulated microgravity are due to an upregulation of the endothelium-dependent nitric oxide/cGMP pathway. Eur J Appl Physiol. 2010 Sep; 110(2):395-404.
      View in: PubMed
    69. Tamariz L, Hare JM. Inflammatory cytokines in heart failure: roles in aetiology and utility as biomarkers. Eur Heart J. 2010 Apr; 31(7):768-70.
      View in: PubMed
    70. Kanashiro-Takeuchi RM, Tziomalos K, Takeuchi LM, Treuer AV, Lamirault G, Dulce R, Hurtado M, Song Y, Block NL, Rick F, Klukovits A, Hu Q, Varga JL, Schally AV, Hare JM. Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction. Proc Natl Acad Sci U S A. 2010 Feb 9; 107(6):2604-9.
      View in: PubMed
    71. Boyle AJ, McNiece IK, Hare JM. Mesenchymal stem cell therapy for cardiac repair. Methods Mol Biol. 2010; 660:65-84.
      View in: PubMed
    72. Heidecker B, Lamirault G, Kasper EK, Wittstein IS, Champion HC, Breton E, Russell SD, Hall J, Kittleson MM, Baughman KL, Hare JM. The gene expression profile of patients with new-onset heart failure reveals important gender-specific differences. Eur Heart J. 2010 May; 31(10):1188-96.
      View in: PubMed
    73. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE, Gammon RS, Hermiller JB, Reisman MA, Schaer GL, Sherman W. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol. 2009 Dec 8; 54(24):2277-86.
      View in: PubMed
    74. Feigenbaum GS, Lemberg L, Hare JM. Tracking cell fate with noninvasive imaging. J Am Coll Cardiol. 2009 Oct 20; 54(17):1627-8.
      View in: PubMed
    75. Trachtenberg BH, Hare JM. Biomarkers of oxidative stress in heart failure. Heart Fail Clin. 2009 Oct; 5(4):561-77.
      View in: PubMed
    76. Beigi F, Oskouei BN, Zheng M, Cooke CA, Lamirault G, Hare JM. Cardiac nitric oxide synthase-1 localization within the cardiomyocyte is accompanied by the adaptor protein, CAPON. Nitric Oxide. 2009 Nov-Dec; 21(3-4):226-33.
      View in: PubMed
    77. Gonzalez DR, Treuer A, Sun QA, Stamler JS, Hare JM. S-Nitrosylation of cardiac ion channels. J Cardiovasc Pharmacol. 2009 Sep; 54(3):188-95.
      View in: PubMed
    78. Quevedo HC, Hatzistergos KE, Oskouei BN, Feigenbaum GS, Rodriguez JE, Valdes D, Pattany PM, Zambrano JP, Hu Q, McNiece I, Heldman AW, Hare JM. Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci U S A. 2009 Aug 18; 106(33):14022-7.
      View in: PubMed
    79. Schuleri KH, Feigenbaum GS, Centola M, Weiss ES, Zimmet JM, Turney J, Kellner J, Zviman MM, Hatzistergos KE, Detrick B, Conte JV, McNiece I, Steenbergen C, Lardo AC, Hare JM. Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. Eur Heart J. 2009 Nov; 30(22):2722-32.
      View in: PubMed
    80. Kittleson MM, Skojec DV, Wittstein IS, Champion HC, Judge DP, Barouch LA, Halushka M, Hare JM, Kasper EK, Russell SD. The change in B-type natriuretic peptide levels over time predicts significant rejection in cardiac transplant recipients. J Heart Lung Transplant. 2009 Jul; 28(7):704-9.
      View in: PubMed
    81. Young KC, Torres E, Hatzistergos KE, Hehre D, Suguihara C, Hare JM. Inhibition of the SDF-1/CXCR4 axis attenuates neonatal hypoxia-induced pulmonary hypertension. Circ Res. 2009 Jun 5; 104(11):1293-301.
      View in: PubMed
    82. Schuleri KH, Centola M, George RT, Amado LC, Evers KS, Kitagawa K, Vavere AL, Evers R, Hare JM, Cox C, McVeigh ER, Lima JA, Lardo AC. Characterization of peri-infarct zone heterogeneity by contrast-enhanced multidetector computed tomography: a comparison with magnetic resonance imaging. J Am Coll Cardiol. 2009 May 5; 53(18):1699-707.
      View in: PubMed
    83. Kanashiro-Takeuchi RM, Heidecker B, Lamirault G, Dharamsi JW, Hare JM. Sex-specific impact of aldosterone receptor antagonism on ventricular remodeling and gene expression after myocardial infarction. Clin Transl Sci. 2009 Apr; 2(2):134-42.
      View in: PubMed
    84. Lima B, Lam GK, Xie L, Diesen DL, Villamizar N, Nienaber J, Messina E, Bowles D, Kontos CD, Hare JM, Stamler JS, Rockman HA. Endogenous S-nitrosothiols protect against myocardial injury. Proc Natl Acad Sci U S A. 2009 Apr 14; 106(15):6297-302.
      View in: PubMed
    85. Tziomalos K, Hare JM. Role of xanthine oxidoreductase in cardiac nitroso-redox imbalance. Front Biosci (Landmark Ed). 2009; 14:237-62.
      View in: PubMed
    86. Hare JM. Translational development of mesenchymal stem cell therapy for cardiovascular diseases. Tex Heart Inst J. 2009; 36(2):145-7.
      View in: PubMed
    87. Schuleri KH, Boyle AJ, Centola M, Amado LC, Evers R, Zimmet JM, Evers KS, Ostbye KM, Scorpio DG, Hare JM, Lardo AC. The adult Göttingen minipig as a model for chronic heart failure after myocardial infarction: focus on cardiovascular imaging and regenerative therapies. Comp Med. 2008 Dec; 58(6):568-79.
      View in: PubMed
    88. Hare JM, Chaparro SV. Cardiac regeneration and stem cell therapy. Curr Opin Organ Transplant. 2008 Oct; 13(5):536-42.
      View in: PubMed
    89. Cooper LT, Hare JM, Tazelaar HD, Edwards WD, Starling RC, Deng MC, Menon S, Mullen GM, Jaski B, Bailey KR, Cunningham MW, Dec GW. Usefulness of immunosuppression for giant cell myocarditis. Am J Cardiol. 2008 Dec 1; 102(11):1535-9.
      View in: PubMed
    90. Heidecker B, Hare JM. Cardiovascular genetic medicine: genomic assessment of prognosis and diagnosis in patients with cardiomyopathy and heart failure. J Cardiovasc Transl Res. 2008 Sep; 1(3):225-31.
      View in: PubMed
    91. Boyle AJ, Schuleri KH, Lienard J, Vaillant R, Chan MY, Zimmet JM, Mazhari R, Centola M, Feigenbaum G, Dib J, Kapur NK, Hare JM, Resar JR. Quantitative automated assessment of myocardial perfusion at cardiac catheterization. Am J Cardiol. 2008 Oct 15; 102(8):980-7.
      View in: PubMed
    92. Heidecker B, Kasper EK, Wittstein IS, Champion HC, Breton E, Russell SD, Kittleson MM, Baughman KL, Hare JM. Transcriptomic biomarkers for individual risk assessment in new-onset heart failure. Circulation. 2008 Jul 15; 118(3):238-46.
      View in: PubMed
    93. Hare JM, Mangal B, Brown J, Fisher C, Freudenberger R, Colucci WS, Mann DL, Liu P, Givertz MM, Schwarz RP. Impact of oxypurinol in patients with symptomatic heart failure. Results of the OPT-CHF study. J Am Coll Cardiol. 2008 Jun 17; 51(24):2301-9.
      View in: PubMed
    94. Sherman W, Dimmeler S, Hare JM, Penn M. Cardiovascular repair and regeneration 2008: the fourth International Conference on Cell Therapy for Cardiovascular Disease (IC3D). EuroIntervention. 2008 May; 4(1):47-9.
      View in: PubMed
    95. Centola M, Schuleri KH, Lardo AC, Hare JM. [Stem cell therapy for myocardial regeneration: mechanisms and current clinical applications]. G Ital Cardiol (Rome). 2008 Apr; 9(4):234-50.
      View in: PubMed
    96. Willens HJ, Chirinos JA, Gomez-Marin O, Fertel DP, Ghany RA, Alfonso CE, Hare JM. Noninvasive differentiation of pulmonary arterial and venous hypertension using conventional and Doppler tissue imaging echocardiography. J Am Soc Echocardiogr. 2008 Jun; 21(6):715-9.
      View in: PubMed
    97. Schuleri KH, Amado LC, Boyle AJ, Centola M, Saliaris AP, Gutman MR, Hatzistergos KE, Oskouei BN, Zimmet JM, Young RG, Heldman AW, Lardo AC, Hare JM. Early improvement in cardiac tissue perfusion due to mesenchymal stem cells. Am J Physiol Heart Circ Physiol. 2008 May; 294(5):H2002-11.
      View in: PubMed
    98. Willens HJ, Chirinos JA, Gómez-Marin O, Hare JM, de Marchena E. Prevalence of mitral annulus calcification in African Americans: comparison with non-Hispanic whites and Hispanics. Ethn Dis. 2008; 18(1):48-52.
      View in: PubMed
    99. Hare JM, Beigi F, Tziomalos K. Nitric oxide and cardiobiology-methods for intact hearts and isolated myocytes. Methods Enzymol. 2008; 441:369-92.
      View in: PubMed
    100. Gonzalez DR, Beigi F, Treuer AV, Hare JM. Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes. Proc Natl Acad Sci U S A. 2007 Dec 18; 104(51):20612-7.
      View in: PubMed
    101. Heldman AW, Hare JM. Cell therapy for myocardial infarction: Special delivery. J Mol Cell Cardiol. 2008 Mar; 44(3):473-6.
      View in: PubMed
    102. Seo D, Hare JM. The transforming growth factor-beta/Smad3 pathway: coming of age as a key participant in cardiac remodeling. Circulation. 2007 Nov 6; 116(19):2096-8.
      View in: PubMed
    103. Gheorghiade M, Rossi JS, Cotts W, Shin DD, Hellkamp AS, Piña IL, Fonarow GC, DeMarco T, Pauly DF, Rogers J, DiSalvo TG, Butler J, Hare JM, Francis GS, Stough WG, O'Connor CM. Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial. Arch Intern Med. 2007 Oct 8; 167(18):1998-2005.
      View in: PubMed
    104. Santhanam L, Lim HK, Lim HK, Miriel V, Brown T, Patel M, Balanson S, Ryoo S, Anderson M, Irani K, Khanday F, Di Costanzo L, Nyhan D, Hare JM, Christianson DW, Rivers R, Shoukas A, Berkowitz DE. Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction. Circ Res. 2007 Sep 28; 101(7):692-702.
      View in: PubMed
    105. Willens HJ, Morales G, Stang RB, Postel C, Hare JM, Chakko SC. Extensive left atrial thrombus in a cocaine user with a bioprosthetic mitral valve, sinus rhythm, and left ventricular dysfunction. Echocardiography. 2007 Jul; 24(6):656-7.
      View in: PubMed
    106. Lima JA, Hare J. Visualizing the coronaries in patients presenting with heart failure of unknown etiology. J Am Coll Cardiol. 2007 May 22; 49(20):2051-2.
      View in: PubMed
    107. Mazhari R, Hare JM. Advances in cell-based therapy for structural heart disease. Prog Cardiovasc Dis. 2007 May-Jun; 49(6):387-95.
      View in: PubMed
    108. Kittleson MM, Bead V, Fradley M, St John ME, Champion HC, Kasper EK, Russell SD, Wittstein IS, Hare JM. Elevated uric acid levels predict allograft vasculopathy in cardiac transplant recipients. J Heart Lung Transplant. 2007 May; 26(5):498-503.
      View in: PubMed
    109. Heidecker B, Hare JM. The use of transcriptomic biomarkers for personalized medicine. Heart Fail Rev. 2007 Mar; 12(1):1-11.
      View in: PubMed
    110. Willens HJ, Byers P, Chirinos JA, Labrador E, Hare JM, de Marchena E. Effects of weight loss after bariatric surgery on epicardial fat measured using echocardiography. Am J Cardiol. 2007 May 1; 99(9):1242-5.
      View in: PubMed
    111. Kittleson MM, St John ME, Bead V, Champion HC, Kasper EK, Russell SD, Wittstein IS, Hare JM. Increased levels of uric acid predict haemodynamic compromise in patients with heart failure independently of B-type natriuretic peptide levels. Heart. 2007 Mar; 93(3):365-7.
      View in: PubMed
    112. Smith RR, Barile L, Cho HC, Leppo MK, Hare JM, Messina E, Giacomello A, Abraham MR, Marbán E. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation. 2007 Feb 20; 115(7):896-908.
      View in: PubMed
    113. Mazhari R, Hare JM. Mechanisms of action of mesenchymal stem cells in cardiac repair: potential influences on the cardiac stem cell niche. Nat Clin Pract Cardiovasc Med. 2007 Feb; 4 Suppl 1:S21-6.
      View in: PubMed
    114. Djelmami-Hani M, Kazemi S, Hare J, Chekanov VS. Induction of heart failure: haemodynamic comparison of three different canine models. Lab Anim. 2007 Jan; 41(1):63-70.
      View in: PubMed
    115. Schuleri KH, Boyle AJ, Hare JM. Mesenchymal stem cells for cardiac regenerative therapy. Handb Exp Pharmacol. 2007; (180):195-218.
      View in: PubMed
    116. Ramos GA, Hare JM. Cardiac cell-based therapy: cell types and mechanisms of actions. Cell Transplant. 2007; 16(9):951-61.
      View in: PubMed
    117. Saraiva RM, Minhas KM, Zheng M, Pitz E, Treuer A, Gonzalez D, Schuleri KH, Vandegaer KM, Barouch LA, Hare JM. Reduced neuronal nitric oxide synthase expression contributes to cardiac oxidative stress and nitroso-redox imbalance in ob/ob mice. Nitric Oxide. 2007 May; 16(3):331-8.
      View in: PubMed
    118. Amado LC, Schuleri KH, Saliaris AP, Boyle AJ, Helm R, Oskouei B, Centola M, Eneboe V, Young R, Lima JA, Lardo AC, Heldman AW, Hare JM. Multimodality noninvasive imaging demonstrates in vivo cardiac regeneration after mesenchymal stem cell therapy. J Am Coll Cardiol. 2006 Nov 21; 48(10):2116-24.
      View in: PubMed
    119. Ardehali R, Reed AS, Owens C, Meininger GR, Conte JV, Hare JM. A long and bumpy road. Am J Med. 2006 Nov; 119(11):923-6.
      View in: PubMed
    120. Saliaris AP, Amado LC, Minhas KM, Schuleri KH, Lehrke S, St John M, Fitton T, Barreiro C, Berry C, Zheng M, Kozielski K, Eneboe V, Brawn J, Hare JM. Chronic allopurinol administration ameliorates maladaptive alterations in Ca2+ cycling proteins and beta-adrenergic hyporesponsiveness in heart failure. Am J Physiol Heart Circ Physiol. 2007 Mar; 292(3):H1328-35.
      View in: PubMed
    121. Zimmet JM, Hare JM. Nitroso-redox interactions in the cardiovascular system. Circulation. 2006 Oct 3; 114(14):1531-44.
      View in: PubMed
    122. Madar I, Ravert HT, Du Y, Hilton J, Volokh L, Dannals RF, Frost JJ, Hare JM. Characterization of uptake of the new PET imaging compound 18F-fluorobenzyl triphenyl phosphonium in dog myocardium. J Nucl Med. 2006 Aug; 47(8):1359-66.
      View in: PubMed
    123. Lehrke S, Mazhari R, Durand DJ, Zheng M, Bedja D, Zimmet JM, Schuleri KH, Chi AS, Gabrielson KL, Hare JM. Aging impairs the beneficial effect of granulocyte colony-stimulating factor and stem cell factor on post-myocardial infarction remodeling. Circ Res. 2006 Sep 1; 99(5):553-60.
      View in: PubMed
    124. Boyle AJ, Schulman SP, Hare JM, Oettgen P. Is stem cell therapy ready for patients? Stem Cell Therapy for Cardiac Repair. Ready for the Next Step . Circulation. 2006 Jul 25; 114(4):339-52.
      View in: PubMed
    125. Oettgen P, Boyle AJ, Schulman SP, Hare JM. Cardiac Stem Cell Therapy. Need for Optimization of Efficacy and Safety Monitoring. Circulation. 2006 Jul 25; 114(4):353-8.
      View in: PubMed
    126. Barth AS, Hare JM. The potential for the transcriptome to serve as a clinical biomarker for cardiovascular diseases. Circ Res. 2006 Jun 23; 98(12):1459-61.
      View in: PubMed
    127. Saraiva RM, Hare JM. Nitric oxide signaling in the cardiovascular system: implications for heart failure. Curr Opin Cardiol. 2006 May; 21(3):221-8.
      View in: PubMed
    128. Eldadah ZA, Rosen B, Hay I, Edvardsen T, Jayam V, Dickfeld T, Meininger GR, Judge DP, Hare J, Lima JB, Calkins H, Berger RD. The benefit of upgrading chronically right ventricle-paced heart failure patients to resynchronization therapy demonstrated by strain rate imaging. Heart Rhythm. 2006 Apr; 3(4):435-42.
      View in: PubMed
    129. Steppan J, Ryoo S, Schuleri KH, Gregg C, Hasan RK, White AR, Bugaj LJ, Khan M, Santhanam L, Nyhan D, Shoukas AA, Hare JM, Berkowitz DE. Arginase modulates myocardial contractility by a nitric oxide synthase 1-dependent mechanism. Proc Natl Acad Sci U S A. 2006 Mar 21; 103(12):4759-64.
      View in: PubMed
    130. Raju SV, Zheng M, Schuleri KH, Phan AC, Bedja D, Saraiva RM, Yiginer O, Vandegaer K, Gabrielson KL, O'donnell CP, Berkowitz DE, Barouch LA, Hare JM. Activation of the cardiac ciliary neurotrophic factor receptor reverses left ventricular hypertrophy in leptin-deficient and leptin-resistant obesity. Proc Natl Acad Sci U S A. 2006 Mar 14; 103(11):4222-7.
      View in: PubMed
    131. Hebert K, Horswell R, Arcement L, Hare J, Stevenson L. The effect of anemia on mortality in indigent patients with mild-to-moderate chronic heart failure. Congest Heart Fail. 2006 Mar-Apr; 12(2):75-9.
      View in: PubMed
    132. Abraham MR, Hare JM. Is skeletal myoblast transplantation proarrhythmic? The jury is still out. Heart Rhythm. 2006 Apr; 3(4):462-3.
      View in: PubMed
    133. Lardo AC, Cordeiro MA, Silva C, Amado LC, George RT, Saliaris AP, Schuleri KH, Fernandes VR, Zviman M, Nazarian S, Halperin HR, Wu KC, Hare JM, Lima JA. Contrast-enhanced multidetector computed tomography viability imaging after myocardial infarction: characterization of myocyte death, microvascular obstruction, and chronic scar. Circulation. 2006 Jan 24; 113(3):394-404.
      View in: PubMed
    134. Schulman SP, Becker LC, Kass DA, Champion HC, Terrin ML, Forman S, Ernst KV, Kelemen MD, Townsend SN, Capriotti A, Hare JM, Gerstenblith G. L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA. 2006 Jan 4; 295(1):58-64.
      View in: PubMed
    135. White AR, Ryoo S, Li D, Champion HC, Steppan J, Wang D, Nyhan D, Shoukas AA, Hare JM, Berkowitz DE. Knockdown of arginase I restores NO signaling in the vasculature of old rats. Hypertension. 2006 Feb; 47(2):245-51.
      View in: PubMed
    136. Minhas KM, Saraiva RM, Schuleri KH, Lehrke S, Zheng M, Saliaris AP, Berry CE, Barouch LA, Vandegaer KM, Li D, Hare JM. Xanthine oxidoreductase inhibition causes reverse remodeling in rats with dilated cardiomyopathy. Circ Res. 2006 Feb 3; 98(2):271-9.
      View in: PubMed
    137. Barouch LA, Gao D, Chen L, Miller KL, Xu W, Phan AC, Kittleson MM, Minhas KM, Berkowitz DE, Wei C, Hare JM. Cardiac myocyte apoptosis is associated with increased DNA damage and decreased survival in murine models of obesity. Circ Res. 2006 Jan 6; 98(1):119-24.
      View in: PubMed
    138. Saraiva RM, Minhas KM, Raju SV, Barouch LA, Pitz E, Schuleri KH, Vandegaer K, Li D, Hare JM. Deficiency of neuronal nitric oxide synthase increases mortality and cardiac remodeling after myocardial infarction: role of nitroso-redox equilibrium. Circulation. 2005 Nov 29; 112(22):3415-22.
      View in: PubMed
    139. Zimmet JM, Hare JM. Emerging role for bone marrow derived mesenchymal stem cells in myocardial regenerative therapy. Basic Res Cardiol. 2005 Nov; 100(6):471-81.
      View in: PubMed
    140. Kittleson MM, Hare JM. Molecular signature analysis: the potential of gene-expression analysis in cardiomyopathy. Future Cardiol. 2005 Nov; 1(6):793-808.
      View in: PubMed
    141. Kittleson MM, Lowenstein CJ, Hare JM. Novel pathogenetic mechanisms in myocarditis: nitric oxide signaling. Heart Fail Clin. 2005 Oct; 1(3):345-61.
      View in: PubMed
    142. Ardehali H, Howard DL, Hariri A, Qasim A, Hare JM, Baughman KL, Kasper EK. A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. Am Heart J. 2005 Sep; 150(3):459-63.
      View in: PubMed
    143. Amado LC, Saliaris AP, Raju SV, Lehrke S, St John M, Xie J, Stewart G, Fitton T, Minhas KM, Brawn J, Hare JM. Xanthine oxidase inhibition ameliorates cardiovascular dysfunction in dogs with pacing-induced heart failure. J Mol Cell Cardiol. 2005 Sep; 39(3):531-6.
      View in: PubMed
    144. Amado LC, Saliaris AP, Schuleri KH, St John M, Xie JS, Cattaneo S, Durand DJ, Fitton T, Kuang JQ, Stewart G, Lehrke S, Baumgartner WW, Martin BJ, Heldman AW, Hare JM. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc Natl Acad Sci U S A. 2005 Aug 9; 102(32):11474-9.
      View in: PubMed
    145. Chang PP, Longenecker JC, Wang NY, Baughman KL, Conte JV, Hare JM, Kasper EK. Mild vs severe pulmonary hypertension before heart transplantation: different effects on posttransplantation pulmonary hypertension and mortality. J Heart Lung Transplant. 2005 Aug; 24(8):998-1007.
      View in: PubMed
    146. Kittleson MM, Minhas KM, Irizarry RA, Ye SQ, Edness G, Breton E, Conte JV, Tomaselli G, Garcia JG, Hare JM. Gene expression in giant cell myocarditis: Altered expression of immune response genes. Int J Cardiol. 2005 Jul 10; 102(2):333-40.
      View in: PubMed
    147. Kittleson MM, Hare JM. Xanthine oxidase inhibitors: an emerging class of drugs for heart failure. Eur Heart J. 2005 Aug; 26(15):1458-60.
      View in: PubMed
    148. Raju SV, Barouch LA, Hare JM. Nitric oxide and oxidative stress in cardiovascular aging. Sci Aging Knowledge Environ. 2005 May 25; 2005(21):re4.
      View in: PubMed
    149. Kittleson MM, Hare JM. Molecular signature analysis: using the myocardial transcriptome as a biomarker in cardiovascular disease. Trends Cardiovasc Med. 2005 May; 15(4):130-8.
      View in: PubMed
    150. Jung AS, Harrison R, Lee KH, Genut J, Nyhan D, Brooks-Asplund EM, Shoukas AA, Hare JM, Berkowitz DE. Simulated microgravity produces attenuated baroreflex-mediated pressor, chronotropic, and inotropic responses in mice. Am J Physiol Heart Circ Physiol. 2005 Aug; 289(2):H600-7.
      View in: PubMed
    151. Kittleson MM, Minhas KM, Irizarry RA, Ye SQ, Edness G, Breton E, Conte JV, Tomaselli G, Garcia JG, Hare JM. Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure. Physiol Genomics. 2005 May 11; 21(3):299-307.
      View in: PubMed
    152. Minhas KM, Khan SA, Raju SV, Phan AC, Gonzalez DR, Skaf MW, Lee K, Tejani AD, Saliaris AP, Saliaris AP, Barouch LA, O'Donnell CP, Emala CW, Berkowitz DE, Hare JM. Leptin repletion restores depressed {beta}-adrenergic contractility in ob/ob mice independently of cardiac hypertrophy. J Physiol. 2005 Jun 1; 565(Pt 2):463-74.
      View in: PubMed
    153. Freudenberger RS, Wilson AC, Lawrence-Nelson J, Hare JM, Kostis JB. Permanent pacing is a risk factor for the development of heart failure. Am J Cardiol. 2005 Mar 1; 95(5):671-4.
      View in: PubMed
    154. Hare JM, Stamler JS. NO/redox disequilibrium in the failing heart and cardiovascular system. J Clin Invest. 2005 Mar; 115(3):509-17.
      View in: PubMed
    155. Bhatia R, Hare JM. Mesenchymal stem cells: future source for reparative medicine. Congest Heart Fail. 2005 Mar-Apr; 11(2):87-91; quiz 92-3.
      View in: PubMed
    156. Starling RC, Hare JM, Hauptman P, McCurry KR, Mayer HW, Kovarik JM, Schmidli H. Therapeutic drug monitoring for everolimus in heart transplant recipients based on exposure-effect modeling. Am J Transplant. 2004 Dec; 4(12):2126-31.
      View in: PubMed
    157. Kittleson MM, Ye SQ, Irizarry RA, Minhas KM, Edness G, Conte JV, Parmigiani G, Miller LW, Chen Y, Hall JL, Garcia JG, Hare JM. Identification of a gene expression profile that differentiates between ischemic and nonischemic cardiomyopathy. Circulation. 2004 Nov 30; 110(22):3444-51.
      View in: PubMed
    158. Hare JM. Nitroso-redox balance in the cardiovascular system. N Engl J Med. 2004 Nov 11; 351(20):2112-4.
      View in: PubMed
    159. Freudenberger RS, Schwarz RP, Brown J, Moore A, Mann D, Givertz MM, Colucci WS, Hare JM. Rationale, design and organisation of an efficacy and safety study of oxypurinol added to standard therapy in patients with NYHA class III - IV congestive heart failure. Expert Opin Investig Drugs. 2004 Nov; 13(11):1509-16.
      View in: PubMed
    160. Khan SA, Lee K, Minhas KM, Gonzalez DR, Raju SV, Tejani AD, Li D, Berkowitz DE, Hare JM. Neuronal nitric oxide synthase negatively regulates xanthine oxidoreductase inhibition of cardiac excitation-contraction coupling. Proc Natl Acad Sci U S A. 2004 Nov 9; 101(45):15944-8.
      View in: PubMed
    161. Townsend SA, Jung AS, Hoe YS, Lefkowitz RY, Khan SA, Lemmon CA, Harrison RW, Lee K, Barouch LA, Cotecchia S, Shoukas AA, Nyhan D, Hare JM, Berkowitz DE. Critical role for the alpha-1B adrenergic receptor at the sympathetic neuroeffector junction. Hypertension. 2004 Nov; 44(5):776-82.
      View in: PubMed
    162. Bristow MR, Krause-Steinrauf H, Nuzzo R, Liang CS, Lindenfeld J, Lowes BD, Hattler B, Abraham WT, Olson L, Krueger S, Thaneemit-Chen S, Hare JM, Loeb HS, Domanski MJ, Eichhorn EJ, Zelis R, Lavori P. Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trial. Circulation. 2004 Sep 14; 110(11):1437-42.
      View in: PubMed
    163. Ardehali H, Qasim A, Cappola T, Howard D, Hruban R, Hare JM, Baughman KL, Kasper EK. Endomyocardial biopsy plays a role in diagnosing patients with unexplained cardiomyopathy. Am Heart J. 2004 May; 147(5):919-23.
      View in: PubMed
    164. Hare JM. Spatial confinement of isoforms of cardiac nitric-oxide synthase: unravelling the complexities of nitric oxide's cardiobiology. Lancet. 2004 Apr 24; 363(9418):1338-9.
      View in: PubMed
    165. Pulerwitz TC, Cappola TP, Felker GM, Hare JM, Baughman KL, Kasper EK. Mortality in primary and secondary myocarditis. Am Heart J. 2004 Apr; 147(4):746-50.
      View in: PubMed
    166. Rahman JE, Helou EF, Gelzer-Bell R, Thompson RE, Kuo C, Rodriguez ER, Hare JM, Baughman KL, Kasper EK. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. J Am Coll Cardiol. 2004 Feb 4; 43(3):410-5.
      View in: PubMed
    167. Leclercq C, Hare JM. Ventricular resynchronization: current state of the art. Circulation. 2004 Jan 27; 109(3):296-9.
      View in: PubMed
    168. Gellman J, Hare JM, Lowenstein CJ, Gerstenblith G, Coombs V, Langenberg P, Brinker JA, Resar JR. L-arginine ameliorates the abnormal sympathetic response of the dysfunctional human coronary microvasculature. Angiology. 2004 Jan-Feb; 55(1):1-8.
      View in: PubMed
    169. Fitton TP, Wei C, Lin R, Bethea BT, Barreiro CJ, Amado L, Gage F, Hare J, Baumgartner WA, Conte JV. Impact of 24 h continuous hypothermic perfusion on heart preservation by assessment of oxidative stress. Clin Transplant. 2004; 18 Suppl 12:22-7.
      View in: PubMed
    170. Berry CE, Hare JM. Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications. J Physiol. 2004 Mar 16; 555(Pt 3):589-606.
      View in: PubMed
    171. Eu JP, Hare JM, Hess DT, Skaf M, Sun J, Cardenas-Navina I, Sun QA, Dewhirst M, Meissner G, Stamler JS. Concerted regulation of skeletal muscle contractility by oxygen tension and endogenous nitric oxide. Proc Natl Acad Sci U S A. 2003 Dec 9; 100(25):15229-34.
      View in: PubMed
    172. Mollura DJ, Hare JM, Rabb H. Stem-cell therapy for renal diseases. Am J Kidney Dis. 2003 Nov; 42(5):891-905.
      View in: PubMed
    173. Yarrow S, Hare J, Robinson KN. Recent trends in tracheal intubation: a retrospective analysis of 97904 cases. Anaesthesia. 2003 Oct; 58(10):1019-22.
      View in: PubMed
    174. Berkowitz DE, White R, Li D, Minhas KM, Cernetich A, Kim S, Burke S, Shoukas AA, Nyhan D, Champion HC, Hare JM. Arginase reciprocally regulates nitric oxide synthase activity and contributes to endothelial dysfunction in aging blood vessels. Circulation. 2003 Oct 21; 108(16):2000-6.
      View in: PubMed
    175. Khan SA, Hare JM. The role of nitric oxide in the physiological regulation of Ca2+ cycling. Curr Opin Drug Discov Devel. 2003 Sep; 6(5):658-66.
      View in: PubMed
    176. Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R, Hare J, Bricker JT, Bowles KR, Towbin JA. Detection of viruses in myocardial tissues by polymerase chain reaction. evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol. 2003 Aug 6; 42(3):466-72.
      View in: PubMed
    177. Barouch LA, Berkowitz DE, Harrison RW, O'Donnell CP, Hare JM. Disruption of leptin signaling contributes to cardiac hypertrophy independently of body weight in mice. Circulation. 2003 Aug 12; 108(6):754-9.
      View in: PubMed
    178. Gaston BM, Hare JM. Hemoglobin and nitric oxide. N Engl J Med. 2003 Jul 24; 349(4):402-5; author reply 402-5.
      View in: PubMed
    179. Hare JM. Nitric oxide and excitation-contraction coupling. J Mol Cell Cardiol. 2003 Jul; 35(7):719-29.
      View in: PubMed
    180. Cappola TP, Cope L, Cernetich A, Barouch LA, Minhas K, Irizarry RA, Parmigiani G, Durrani S, Lavoie T, Hoffman EP, Ye SQ, Garcia JG, Hare JM. Deficiency of different nitric oxide synthase isoforms activates divergent transcriptional programs in cardiac hypertrophy. Physiol Genomics. 2003 Jun 24; 14(1):25-34.
      View in: PubMed
    181. Barouch LA, Cappola TP, Harrison RW, Crone JK, Rodriguez ER, Burnett AL, Hare JM. Combined loss of neuronal and endothelial nitric oxide synthase causes premature mortality and age-related hypertrophic cardiac remodeling in mice. J Mol Cell Cardiol. 2003 Jun; 35(6):637-44.
      View in: PubMed
    182. Khan SA, Skaf MW, Harrison RW, Lee K, Minhas KM, Kumar A, Fradley M, Shoukas AA, Berkowitz DE, Hare JM. Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases. Circ Res. 2003 Jun 27; 92(12):1322-9.
      View in: PubMed
    183. Kraitchman DL, Heldman AW, Atalar E, Amado LC, Martin BJ, Pittenger MF, Hare JM, Bulte JW. In vivo magnetic resonance imaging of mesenchymal stem cells in myocardial infarction. Circulation. 2003 May 13; 107(18):2290-3.
      View in: PubMed
    184. Hare JM, Johnson RJ. Uric acid predicts clinical outcomes in heart failure: insights regarding the role of xanthine oxidase and uric acid in disease pathophysiology. Circulation. 2003 Apr 22; 107(15):1951-3.
      View in: PubMed
    185. Okura Y, Dec GW, Hare JM, Kodama M, Berry GJ, Tazelaar HD, Bailey KR, Cooper LT. A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis. J Am Coll Cardiol. 2003 Jan 15; 41(2):322-9.
      View in: PubMed
    186. Champion HC, Skaf MW, Hare JM. Role of nitric oxide in the pathophysiology of heart failure. Heart Fail Rev. 2003 Jan; 8(1):35-46.
      View in: PubMed
    187. Hare JM, Nguyen GC, Massaro AF, Drazen JM, Stevenson LW, Colucci WS, Fang JC, Johnson W, Givertz MM, Lucas C. Exhaled nitric oxide: a marker of pulmonary hemodynamics in heart failure. J Am Coll Cardiol. 2002 Sep 18; 40(6):1114-9.
      View in: PubMed
    188. Hare JM. Cardiac-resynchronization therapy for heart failure. N Engl J Med. 2002 Jun 13; 346(24):1902-5.
      View in: PubMed
    189. Cappola TP, Felker GM, Kao WH, Hare JM, Baughman KL, Kasper EK. Pulmonary hypertension and risk of death in cardiomyopathy: patients with myocarditis are at higher risk. Circulation. 2002 Apr 9; 105(14):1663-8.
      View in: PubMed
    190. Barouch LA, Harrison RW, Skaf MW, Rosas GO, Cappola TP, Kobeissi ZA, Hobai IA, Lemmon CA, Burnett AL, O'Rourke B, Rodriguez ER, Huang PL, Lima JA, Berkowitz DE, Hare JM. Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature. 2002 Mar 21; 416(6878):337-9.
      View in: PubMed
    191. Saavedra WF, Paolocci N, St John ME, Skaf MW, Stewart GC, Xie JS, Harrison RW, Zeichner J, Mudrick D, Marbán E, Kass DA, Hare JM. Imbalance between xanthine oxidase and nitric oxide synthase signaling pathways underlies mechanoenergetic uncoupling in the failing heart. Circ Res. 2002 Feb 22; 90(3):297-304.
      View in: PubMed
    192. Cappola TP, Kass DA, Nelson GS, Berger RD, Rosas GO, Kobeissi ZA, Marbán E, Hare JM. Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy. Circulation. 2001 Nov 13; 104(20):2407-11.
      View in: PubMed
    193. Wu KC, Heldman AW, Brinker JA, Hare JM, Lima JA. Microvascular obstruction after nonsurgical septal reduction for the treatment of hypertrophic cardiomyopathy. Circulation. 2001 Oct 9; 104(15):1868.
      View in: PubMed
    194. Rosas GO, Zieman SJ, Donabedian M, Vandegaer K, Hare JM. Augmented age-associated innate immune responses contribute to negative inotropic and lusitropic effects of lipopolysaccharide and interferon gamma. J Mol Cell Cardiol. 2001 Oct; 33(10):1849-59.
      View in: PubMed
    195. Meininger GR, Nadasdy T, Hruban RH, Bollinger RC, Baughman KL, Hare JM. Chronic active myocarditis following acute Bartonella henselae infection (cat scratch disease). Am J Surg Pathol. 2001 Sep; 25(9):1211-4.
      View in: PubMed
    196. Paolocci N, Saavedra WF, Miranda KM, Martignani C, Isoda T, Hare JM, Espey MG, Fukuto JM, Feelisch M, Wink DA, Kass DA. Nitroxyl anion exerts redox-sensitive positive cardiac inotropy in vivo by calcitonin gene-related peptide signaling. Proc Natl Acad Sci U S A. 2001 Aug 28; 98(18):10463-8.
      View in: PubMed
    197. Hare JM. Oxidative stress and apoptosis in heart failure progression. Circ Res. 2001 Aug 3; 89(3):198-200.
      View in: PubMed
    198. Senzaki H, Smith CJ, Juang GJ, Isoda T, Mayer SP, Ohler A, Paolocci N, Tomaselli GF, Hare JM, Kass DA. Cardiac phosphodiesterase 5 (cGMP-specific) modulates beta-adrenergic signaling in vivo and is down-regulated in heart failure. FASEB J. 2001 Aug; 15(10):1718-26.
      View in: PubMed
    199. Wittstein IS, Kass DA, Pak PH, Maughan WL, Fetics B, Hare JM. Cardiac nitric oxide production due to angiotensin-converting enzyme inhibition decreases beta-adrenergic myocardial contractility in patients with dilated cardiomyopathy. J Am Coll Cardiol. 2001 Aug; 38(2):429-35.
      View in: PubMed
    200. Hare JM, Baughman KL. Fulminant and acute lymphocytic myocarditis: the prognostic value of clinicopathological classification. Eur Heart J. 2001 Feb; 22(4):269-70.
      View in: PubMed
    201. Zieman SJ, Gerstenblith G, Lakatta EG, Rosas GO, Vandegaer K, Ricker KM, Hare JM. Upregulation of the nitric oxide-cGMP pathway in aged myocardium: physiological response to l-arginine. Circ Res. 2001 Jan 19; 88(1):97-102.
      View in: PubMed
    202. Lofthouse RA, Davis JR, Frondoza CG, Jinnah RH, Hungerford DS, Hare JM. Identification of caveolae and detection of caveolin in normal human osteoblasts. J Bone Joint Surg Br. 2001 Jan; 83(1):124-9.
      View in: PubMed
    203. Nelson GS, Berger RD, Fetics BJ, Talbot M, Spinelli JC, Hare JM, Kass DA. Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block. Circulation. 2000 Dec 19; 102(25):3053-9.
      View in: PubMed
    204. Felker GM, Jaeger CJ, Klodas E, Thiemann DR, Hare JM, Hruban RH, Kasper EK, Baughman KL. Myocarditis and long-term survival in peripartum cardiomyopathy. Am Heart J. 2000 Nov; 140(5):785-91.
      View in: PubMed
    205. Slawsky MT, Colucci WS, Gottlieb SS, Greenberg BH, Haeusslein E, Hare J, Hutchins S, Leier CV, LeJemtel TH, Loh E, Nicklas J, Ogilby D, Singh BN, Smith W. Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Study Investigators. Circulation. 2000 Oct 31; 102(18):2222-7.
      View in: PubMed
    206. Paolocci N, Ekelund UE, Isoda T, Ozaki M, Vandegaer K, Georgakopoulos D, Harrison RW, Kass DA, Hare JM. cGMP-independent inotropic effects of nitric oxide and peroxynitrite donors: potential role for nitrosylation. Am J Physiol Heart Circ Physiol. 2000 Oct; 279(4):H1982-8.
      View in: PubMed
    207. Hare J, Skinner D, Riley D. Why older age predicts lower acceptance of physician-assisted suicide. WMJ. 2000 Oct; 99(7):20-7, 46.
      View in: PubMed
    208. Varghese P, Harrison RW, Lofthouse RA, Georgakopoulos D, Berkowitz DE, Hare JM. beta(3)-adrenoceptor deficiency blocks nitric oxide-dependent inhibition of myocardial contractility. J Clin Invest. 2000 Sep; 106(5):697-703.
      View in: PubMed
    209. Chekanov VS, Tchekanov GV, Rieder MA, Hare J, Mortada M. Effects of electrical stimulation postcardiomyoplasty in a model of chronic heart failure: hemodynamic results after daily 12-hour cessation versus a nonstop regimen. Pacing Clin Electrophysiol. 2000 Jul; 23(7):1094-102.
      View in: PubMed
    210. Felker GM, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Baughman KL, Hare JM. Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol. 2000 Jul; 36(1):227-32.
      View in: PubMed
    211. Givertz MM, Colucci WS, LeJemtel TH, Gottlieb SS, Hare JM, Slawsky MT, Leier CV, Loh E, Nicklas JM, Lewis BE. Acute endothelin A receptor blockade causes selective pulmonary vasodilation in patients with chronic heart failure. Circulation. 2000 Jun 27; 101(25):2922-7.
      View in: PubMed
    212. Hare JM, Lofthouse RA, Juang GJ, Colman L, Ricker KM, Kim B, Senzaki H, Cao S, Tunin RS, Kass DA. Contribution of caveolin protein abundance to augmented nitric oxide signaling in conscious dogs with pacing-induced heart failure. Circ Res. 2000 May 26; 86(10):1085-92.
      View in: PubMed
    213. Harrison RW, Thakkar RN, Senzaki H, Ekelund UE, Cho E, Kass DA, Hare JM. Relative contribution of preload and afterload to the reduction in cardiac output caused by nitric oxide synthase inhibition with L-N(G)-methylarginine hydrochloride 546C88. Crit Care Med. 2000 May; 28(5):1263-8.
      View in: PubMed
    214. Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baughman KL, Kasper EK. Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N Engl J Med. 2000 Apr 13; 342(15):1077-84.
      View in: PubMed
    215. McCarthy RE, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, Baughman KL. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med. 2000 Mar 9; 342(10):690-5.
      View in: PubMed
    216. Senzaki H, Isoda T, Paolocci N, Ekelund U, Hare JM, Kass DA. Improved mechanoenergetics and cardiac rest and reserve function of in vivo failing heart by calcium sensitizer EMD-57033. Circulation. 2000 Mar 7; 101(9):1040-8.
      View in: PubMed
    217. Hare JM, Kass DA, Stamler JS. The physiological response to cardiovascular 'orphan' G protein-coupled receptor agonists. Nat Med. 1999 Nov; 5(11):1241-2.
      View in: PubMed
    218. Asfour B, Hare JM, Kohl T, Baba HA, Kass DA, Chen K, Tjan TD, Hammel D, Weyand M, Hruban RH, Scheld HH, Byrne BJ. A simple new model of physiologically working heterotopic rat heart transplantation provides hemodynamic performance equivalent to that of an orthotopic heart. J Heart Lung Transplant. 1999 Oct; 18(10):927-36.
      View in: PubMed
    219. Ekelund UE, Harrison RW, Shokek O, Thakkar RN, Tunin RS, Senzaki H, Kass DA, Marbán E, Hare JM. Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure. Circ Res. 1999 Sep 3; 85(5):437-45.
      View in: PubMed
    220. Hare JM, McDonough KA. High-frequency RecA-dependent and -independent mechanisms of Congo red binding mutations in Yersinia pestis. J Bacteriol. 1999 Aug; 181(16):4896-904.
      View in: PubMed
    221. Felker GM, Hu W, Hare JM, Hruban RH, Baughman KL, Kasper EK. The spectrum of dilated cardiomyopathy. The Johns Hopkins experience with 1,278 patients. Medicine (Baltimore). 1999 Jul; 78(4):270-83.
      View in: PubMed
    222. Hare JM, Stamler JS. NOS: modulator, not mediator of cardiac performance. Nat Med. 1999 Mar; 5(3):273-4.
      View in: PubMed
    223. Pauly DF, Morss SE, Tanio JW, Irani K, Cameron DE, Schulman SP, Hare JM. Reduced left ventricular dimension and normalized atrial natriuretic hormone level after repair of aortic coarctation in an adult. Clin Cardiol. 1999 Mar; 22(3):233-5.
      View in: PubMed
    224. Hare JM, Wagner AK, McDonough KA. Independent acquisition and insertion into different chromosomal locations of the same pathogenicity island in Yersinia pestis and Yersinia pseudotuberculosis. Mol Microbiol. 1999 Jan; 31(1):291-303.
      View in: PubMed
    225. Jumrussirikul P, Dinerman J, Dawson TM, Dawson VL, Ekelund U, Georgakopoulos D, Schramm LP, Calkins H, Snyder SH, Hare JM, Berger RD. Interaction between neuronal nitric oxide synthase and inhibitory G protein activity in heart rate regulation in conscious mice. J Clin Invest. 1998 Oct 1; 102(7):1279-85.
      View in: PubMed
    226. Krum D, Hare J, Mughal K, Jazayeri MR, Deshpande S, Dhala A, Blanck Z, Akhtar M, Sra J. Optimization of shocking lead configuration for transvenous atrial defibrillation. J Cardiovasc Electrophysiol. 1998 Sep; 9(9):998-1003.
      View in: PubMed
    227. Hrobon P, Kuntz KM, Hare JM. Should endomyocardial biopsy be performed for detection of myocarditis? A decision analytic approach. J Heart Lung Transplant. 1998 May; 17(5):479-86.
      View in: PubMed
    228. Georgakopoulos D, Mitzner WA, Chen CH, Byrne BJ, Millar HD, Hare JM, Kass DA. In vivo murine left ventricular pressure-volume relations by miniaturized conductance micromanometry. Am J Physiol. 1998 Apr; 274(4 Pt 2):H1416-22.
      View in: PubMed
    229. Hare JM, Kim B, Flavahan NA, Ricker KM, Peng X, Colman L, Weiss RG, Kass DA. Pertussis toxin-sensitive G proteins influence nitric oxide synthase III activity and protein levels in rat heart. J Clin Invest. 1998 Mar 15; 101(6):1424-31.
      View in: PubMed
    230. Kass DA, Hare JM, Georgakopoulos D. Murine cardiac function: a cautionary tail. Circ Res. 1998 Mar 9; 82(4):519-22.
      View in: PubMed
    231. Hare JM, Givertz MM, Creager MA, Colucci WS. Increased sensitivity to nitric oxide synthase inhibition in patients with heart failure: potentiation of beta-adrenergic inotropic responsiveness. Circulation. 1998 Jan 20; 97(2):161-6.
      View in: PubMed
    232. Avitall B, Mughal K, Hare J, Helms R, Krum D. The effects of electrode-tissue contact on radiofrequency lesion generation. Pacing Clin Electrophysiol. 1997 Dec; 20(12 Pt 1):2899-910.
      View in: PubMed
    233. Keelan ET, Krum D, Hare J, Mughal K, Li H, Akhtar M, Jazayeri MR. Safety of atrial defibrillation shocks synchronized to narrow and wide QRS complexes during atrial pacing protocols simulating atrial fibrillation in dogs. Circulation. 1997 Sep 16; 96(6):2022-30.
      View in: PubMed
    234. Hare JM, Shernan SK, Body SC, Graydon E, Colucci WS, Couper GS. Influence of inhaled nitric oxide on systemic flow and ventricular filling pressure in patients receiving mechanical circulatory assistance. Circulation. 1997 May 6; 95(9):2250-3.
      View in: PubMed
    235. McDonough KA, Hare JM. Homology with a repeated Yersinia pestis DNA sequence IS100 correlates with pesticin sensitivity in Yersinia pseudotuberculosis. J Bacteriol. 1997 Mar; 179(6):2081-5.
      View in: PubMed
    236. Keaney JF, Hare JM, Balligand JL, Loscalzo J, Smith TW, Colucci WS. Inhibition of nitric oxide synthase augments myocardial contractile responses to beta-adrenergic stimulation. Am J Physiol. 1996 Dec; 271(6 Pt 2):H2646-52.
      View in: PubMed
    237. Givertz MM, Hare JM, Loh E, Gauthier DF, Colucci WS. Effect of bolus milrinone on hemodynamic variables and pulmonary vascular resistance in patients with severe left ventricular dysfunction: a rapid test for reversibility of pulmonary hypertension. J Am Coll Cardiol. 1996 Dec; 28(7):1775-80.
      View in: PubMed
    238. Li H, Hare J, Mughal K, Krum D, Biehl M, Deshpande S, Dhala A, Blanck Z, Sra J, Jazayeri M, Akhtar M. Distribution of atrial electrogram types during atrial fibrillation: effect of rapid atrial pacing and intercaval junction ablation. J Am Coll Cardiol. 1996 Jun; 27(7):1713-21.
      View in: PubMed
    239. Campbell C, Hare J, Nelson C. Physician-assisted suicide. JAMA. 1995 Dec 27; 274(24):1910-1; author reply 1912.
      View in: PubMed
    240. Hare JM, Loh E, Creager MA, Colucci WS. Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction. Circulation. 1995 Oct 15; 92(8):2198-203.
      View in: PubMed
    241. Hare JM, Colucci WS. Role of nitric oxide in the regulation of myocardial function. Prog Cardiovasc Dis. 1995 Sep-Oct; 38(2):155-66.
      View in: PubMed
    242. Hare JM, Keaney JF, Balligand JL, Loscalzo J, Smith TW, Colucci WS. Role of nitric oxide in parasympathetic modulation of beta-adrenergic myocardial contractility in normal dogs. J Clin Invest. 1995 Jan; 95(1):360-6.
      View in: PubMed
    243. Loh E, Stamler JS, Hare JM, Loscalzo J, Colucci WS. Cardiovascular effects of inhaled nitric oxide in patients with left ventricular dysfunction. Circulation. 1994 Dec; 90(6):2780-5.
      View in: PubMed
    244. Avitall B, Stormo A, Barragry T, Axtel K, Hare J. Sudden cardiac death: Twiddler's syndrome with an implantable cardioverter defibrillator. Am Heart J. 1994 Oct; 128(4):833-6.
      View in: PubMed
    245. Edelman RR, Gaa J, Wedeen VJ, Loh E, Hare JM, Prasad P, Li W. In vivo measurement of water diffusion in the human heart. Magn Reson Med. 1994 Sep; 32(3):423-8.
      View in: PubMed
    246. Avitall B, Hare J, Krum D, Dhala A. The anatomical determinants for the design of intracardiac mapping and ablation catheters. Pacing Clin Electrophysiol. 1994 May; 17(5 Pt 1):908-18.
      View in: PubMed
    247. Kasper EK, Agema WR, Hutchins GM, Deckers JW, Hare JM, Baughman KL. The causes of dilated cardiomyopathy: a clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol. 1994 Mar 1; 23(3):586-90.
      View in: PubMed
    248. Avitall B, Hare J, Zander G, Lessila C, Dhala A, Deshpande S, Jazayeri M, Sra J, Akhtar M. Cardioversion, defibrillation, and overdrive pacing of ventricular arrhythmias: the effect of moricizine in dogs with sustained monomorphic ventricular tachycardia. Pacing Clin Electrophysiol. 1993 Nov; 16(11):2092-7.
      View in: PubMed
    249. Avitall B, Khan M, Krum D, Jazayeri M, Hare J. Repeated use of ablation catheters: a prospective study. J Am Coll Cardiol. 1993 Nov 1; 22(5):1367-72.
      View in: PubMed
    250. Avitall B, Khan M, Krum D, Hare J, Lessila C, Dhala A, Deshpande S, Jazayeri M, Sra J, Akhtar M. Physics and engineering of transcatheter cardiac tissue ablation. J Am Coll Cardiol. 1993 Sep; 22(3):921-32.
      View in: PubMed
    251. Coleman N, Greenfield IM, Hare J, Kruger-Gray H, Chain BM, Stanley MA. Characterization and functional analysis of the expression of intercellular adhesion molecule-1 in human papillomavirus-related disease of cervical keratinocytes. Am J Pathol. 1993 Aug; 143(2):355-67.
      View in: PubMed
    252. Hare JM, Walford GD, Hruban RH, Hutchins GM, Deckers JW, Baughman KL. Ischemic cardiomyopathy: endomyocardial biopsy and ventriculographic evaluation of patients with congestive heart failure, dilated cardiomyopathy and coronary artery disease. J Am Coll Cardiol. 1992 Nov 15; 20(6):1318-25.
      View in: PubMed
    253. Hare J, Pratt C, Nelson C. Agreement between patients and their self-selected surrogates on difficult medical decisions. Arch Intern Med. 1992 May; 152(5):1049-54.
      View in: PubMed
    254. Avitall B, Hare J, Zander G, Bockoff C, Tchou P, Jazayeri M, Akhtar M. Iontophoretic transmyocardial drug delivery. A novel approach to antiarrhythmic drug therapy. Circulation. 1992 Apr; 85(4):1582-93.
      View in: PubMed
    255. Deckers JW, Hare JM, Baughman KL. Complications of transvenous right ventricular endomyocardial biopsy in adult patients with cardiomyopathy: a seven-year survey of 546 consecutive diagnostic procedures in a tertiary referral center. J Am Coll Cardiol. 1992 Jan; 19(1):43-7.
      View in: PubMed
    256. Hare JM, Baughman KL, Kass DA, Goodman SN, Ladenson PW. Influence of dilated cardiomyopathy, myocarditis and cardiac transplantation on the relation between plasma atrial natriuretic factor and atrial pressures. Am J Cardiol. 1991 Feb 15; 67(5):391-7.
      View in: PubMed
    257. Singer DS, Hare J, Golding H, Flaherty L, Rudikoff S. Characterization of a new subfamily of class I genes in the H-2 complex of the mouse. Immunogenetics. 1988; 28(1):13-21.
      View in: PubMed
    258. Foster C, Lemberger K, Thompson NN, Sennett SM, Hare J, Pollock ML, Pels AE, Schmidt DH. Functional translation of exercise responses from graded exercise testing to exercise training. Am Heart J. 1986 Dec; 112(6):1309-16.
      View in: PubMed
    259. Foster C, Jackson AS, Pollock ML, Taylor MM, Hare J, Sennett SM, Rod JL, Sarwar M, Schmidt DH. Generalized equations for predicting functional capacity from treadmill performance. Am Heart J. 1984 Jun; 107(6):1229-34.
      View in: PubMed
    260. Farrell PA, Maksud MG, Pollock ML, Foster C, Anholm J, Hare J, Leon AS. A comparison of plasma cholesterol, triglycerides, and high density lipoprotein-cholesterol in speed skaters, weightlifters and non-athletes. Eur J Appl Physiol Occup Physiol. 1982; 48(1):77-82.
      View in: PubMed
    261. Feniuk W, Hare J, Humphrey PP. An analysis of the mechanism of 5-hydroxytryptamine-induced vasopressor responses in ganglion-blocked anaesthetized dogs. J Pharm Pharmacol. 1981 Mar; 33(3):155-60.
      View in: PubMed
    262. Hall J, Hare J, Douglas M. Adenocarcinoma of the colon presenting as anaemia. Med J Aust. 1977 Jul 9; 2(2):61-2.
      View in: PubMed
    Hare's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067